Auffarth Gerd 4
4 · Outlook Therapeutics, Inc. · Filed Jul 6, 2020
Insider Transaction Report
Form 4
Auffarth Gerd
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-07-01$0.99/sh+19,874$19,582→ 19,874 totalExercise: $1.28Exp: 2030-07-01→ Common Stock (19,874 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") in lieu of $19,582.42 cash fees payable under the Issuer's non-employee Director compensation program, and vest on the last day of the remaining fiscal quarter such that they are vested in full on September 30, 2020, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan.